Table 2.
Comparison of centres regarding MIBI SPECT data and 5-year clinical outcomes
| On-site (n = 60) | Off-site (n = 68) | p | |
|---|---|---|---|
| Death or infarct | 11 (18%) | 14 (21%) | 0.75 |
| LVESV (ml) | 58 ± 26 | 65 ± 31 | 0.17 |
| LVEDV (ml) | 118 ± 36 | 124 ± 38 | 0.34 |
| LVEF (%) | 52 ± 12 | 50 ± 11 | 0.06 |
| Infarct extent (%) | 14 ± 12 | 17 ± 15 | 0.34 |
| SRS | 11 ± 9.6 | 12 ± 12 | 0.33 |
| SMS | 19 ± 13 | 24 ± 20 | 0.06 |
| STS | 14 ± 12 | 17 ± 15 | 0.028 |
| Peak CK | 1611 ± 1838 | 1894 ± 1609 | 0.35 |
| Peak CK-MB (U/l) | 161 ± 136 | 204 ± 160 | 0.11 |
Continuous data are presented as mean values ± standard deviation. Dichotomous data are presented as numbers and percentages
SPECT single photon emission computed tomography, LVESV left ventricular end-systolic volume, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, SRS summed rest score, SMS summed motion score, STS summed thickening score, CK creatine kinase